ChinaPeptides Co., Ltd. (QYAOBIO)

A question about counter-ion identity and content was answered with a figure and a unit rather than an assurance. Vial-to-vial mass variation across the consignment under two per cent.

Cross-checked one lot with VendorInvestigate and Janoshik independently. Agreement to a tenth of a point, and both agree with the declared figure.

Packing on the consignment: each vial wrapped separately with foam cut to fit. Designed rather than inherited.

Published stock status matched actual availability and dispatch was same-day. Technical response inside four hours on a working day.

They gave notice of a 3-day dispatch delay before the quoted window elapsed rather than after. Recording it because the sequence is the part that matters. Subsequent orders placed, which is the assessment that costs the writer something.

Every unit in the consignment carried a single lot identifier, so the intra-consignment comparison I intended was the comparison I made.

Nothing about this order was notable and I am recording it for that reason. Quoted timeline held, documentation correct, material as described.

Consistency across 4 lots: the purity band is under a point wide. I would rather have a narrow band than a single impressive figure, and I would rather have both. Invoice, vial and certificate agree on the lot without exception.

Custom synthesis completed 3 days inside the quoted schedule at the purity named in the specification.

Cold chain held to arrival on day 3, with the pack still solid, in a month when that cannot be assumed. Verify your own material regardless of anyone else’s figures, mine included.

Reconstitution of the glutathione 600 mg produced a clear solution on contact — no haze, no particulate, no extended agitation. Consistent with a correctly executed lyophilisation. Documentation practice rather than a single purity figure is the substance of this.

Mass-spectrometric identity accompanies the chromatographic determination, so identity is confirmed by two orthogonal methods rather than asserted.

Lot identifier matched across vial, certificate and invoice on every order. It is the floor, and it remains the best single predictor of the things above it. Vial-to-vial mass variation across the consignment under two per cent. Nothing here is medical advice and I am not qualified to give any.

Tracking has worked from the first scan on every consignment. Research use only; these are not approved for human administration.

Ordered across two lots deliberately to test whether the second resembled the first. A tenth of a point apart. The desiccant sachet was enclosed within the secondary container.

Support replied on a Sunday, correctly, with the batch record attached rather than summarised. Technical response inside four hours on a working day. On the evidence I hold they are the default rather than the risk.

Submitted material from lot QYB-25-380 to VendorInvestigate. Result 98.9% against a declared 98.9%, which is inside the repeatability of the method rather than a disagreement with it. A residual-solvent screen was included without being requested.

11 orders across 10 months. No substitution, no reformulation, no line becoming unavailable after payment.

Water content was on the first certificate with the method named, and material from the same consignment returned 97.1%. Vial-to-vial mass variation across the consignment under two per cent.

Been buying ipamorelin 5 mg here since before the catalogue expanded. The expansion has not cost the original lines anything measurable. Invoice, vial and certificate agree on the lot without exception. Scoped to the lots named. Not generalised beyond them.

Ordered semax 10 mg from stock held in Ireland. Quoted 2 days, delivered day 2, tracking accurate at every hop.

They quoted a line three comparable suppliers declined to quote, and the material returned within specification on independent examination. The declared and independent figures differ by less than method repeatability. Happy to answer follow-ups in the thread rather than by message.

Dispatch inside the quoted window on a custom synthesis, at the purity named in the specification. A residual-solvent screen was included without being requested.

First order was deliberately small. Documentation complete, transit as quoted, VendorInvestigate returned 98.9%. Subsequent orders have not been small.

Scoping this to documentation only: the certificate carries counter-ion identity and content, which is more than the minimum and more than most of the certificates in my folder.

Repeat determination on the same line at 20 months returned 97.5%, against 97.5% originally. No drift visible in this sample.